Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARBOPLATIN Cause Disease progression? 4,538 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 4,538 reports of Disease progression have been filed in association with CARBOPLATIN (Carboplatin). This represents 5.4% of all adverse event reports for CARBOPLATIN.

4,538
Reports of Disease progression with CARBOPLATIN
5.4%
of all CARBOPLATIN reports
1,159
Deaths
618
Hospitalizations

How Dangerous Is Disease progression From CARBOPLATIN?

Of the 4,538 reports, 1,159 (25.5%) resulted in death, 618 (13.6%) required hospitalization, and 102 (2.2%) were considered life-threatening.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN. However, 4,538 reports have been filed with the FAERS database.

What Other Side Effects Does CARBOPLATIN Cause?

Off label use (6,100) Neutropenia (5,314) Anaemia (5,312) Febrile neutropenia (4,888) Nausea (4,588) Thrombocytopenia (4,483) Malignant neoplasm progression (4,177) Diarrhoea (4,154) Dyspnoea (3,494) Drug ineffective (3,377)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CAPECITABINE (3,808) ETOPOSIDE (3,776) CISPLATIN (3,746)

Which CARBOPLATIN Alternatives Have Lower Disease progression Risk?

CARBOPLATIN vs CARBOPROST TROMETHAMINE CARBOPLATIN vs CARBOXYMETHYLCELLULOSE CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN\POLYSORBATE 80 CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\HYPROMELLOSES

Related Pages

CARBOPLATIN Full Profile All Disease progression Reports All Drugs Causing Disease progression CARBOPLATIN Demographics